FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2608839610> ?p ?o ?g. }

• W2608839610 endingPage "137.e1" @default.
• W2608839610 startingPage "131" @default.
• W2608839610 abstract "Objective To evaluate treatment, ocular complications and outcomes of children with pediatric uveitis not associated with juvenile idiopathic arthritis. Study design This was a retrospective chart review of pediatric uveitis in children under 16 years of age, recruited from the pediatric rheumatology department at Bicêtre Hospital from 2005 to 2015. Patients with juvenile idiopathic arthritis-associated and infectious uveitis were excluded. We used the Standardization of Uveitis Nomenclature Working Group to classify uveitis, disease activity, and treatment end points. Results We enrolled 56 patients and 102 affected eyes. The mean age at diagnosis was 10 ± 3.5 years (range 3-15), and the mean follow-up 4.2 ± 3.3 years (1-15). The main diagnoses were idiopathic (55%), Behçet disease (15%), and sarcoidosis (5%). The main localization was panuveitis in 44 of 102 eyes (43%). Corticosteroid sparing treatment was needed in 62 of 102 eyes (60%). Second-line therapies included methotrexate and azathioprine, and the third-line therapy was a biologic agent, mainly infliximab, in 33 of 102 eyes (32%). Infliximab achieved uveitis inactivity in 14 of 18 eyes (80%), in all etiologies. Severe complications were present in 68 of 102 eyes (67%). The most common were synechiae 33% of eyes, cataract (20%), and macular edema (25%). Of these, 37% were present at diagnosis. Remission was achieved in 22 of 102 eyes (21%). Conclusions Conventional therapies were insufficient to treat many of the cases of posterior or panuveitis. This study underlines the need for earlier and more aggressive treatment and antitumor necrosis factor-α therapy was rapidly efficient in most cases of refractory uveitis. To evaluate treatment, ocular complications and outcomes of children with pediatric uveitis not associated with juvenile idiopathic arthritis. This was a retrospective chart review of pediatric uveitis in children under 16 years of age, recruited from the pediatric rheumatology department at Bicêtre Hospital from 2005 to 2015. Patients with juvenile idiopathic arthritis-associated and infectious uveitis were excluded. We used the Standardization of Uveitis Nomenclature Working Group to classify uveitis, disease activity, and treatment end points. We enrolled 56 patients and 102 affected eyes. The mean age at diagnosis was 10 ± 3.5 years (range 3-15), and the mean follow-up 4.2 ± 3.3 years (1-15). The main diagnoses were idiopathic (55%), Behçet disease (15%), and sarcoidosis (5%). The main localization was panuveitis in 44 of 102 eyes (43%). Corticosteroid sparing treatment was needed in 62 of 102 eyes (60%). Second-line therapies included methotrexate and azathioprine, and the third-line therapy was a biologic agent, mainly infliximab, in 33 of 102 eyes (32%). Infliximab achieved uveitis inactivity in 14 of 18 eyes (80%), in all etiologies. Severe complications were present in 68 of 102 eyes (67%). The most common were synechiae 33% of eyes, cataract (20%), and macular edema (25%). Of these, 37% were present at diagnosis. Remission was achieved in 22 of 102 eyes (21%). Conventional therapies were insufficient to treat many of the cases of posterior or panuveitis. This study underlines the need for earlier and more aggressive treatment and antitumor necrosis factor-α therapy was rapidly efficient in most cases of refractory uveitis." @default.
• W2608839610 created "2017-05-05" @default.
• W2608839610 creator A5035292611 @default.
• W2608839610 creator A5036816060 @default.
• W2608839610 creator A5052865753 @default.
• W2608839610 creator A5060687162 @default.
• W2608839610 creator A5083808896 @default.
• W2608839610 creator A5086216178 @default.
• W2608839610 date "2017-07-01" @default.
• W2608839610 modified "2023-10-14" @default.
• W2608839610 title "Retrospective Study Evaluating Treatment Decisions and Outcomes of Childhood Uveitis Not Associated with Juvenile Idiopathic Arthritis" @default.
• W2608839610 cites W1504389907 @default.
• W2608839610 cites W1530431523 @default.
• W2608839610 cites W1768609978 @default.
• W2608839610 cites W1942649327 @default.
• W2608839610 cites W1984188767 @default.
• W2608839610 cites W1989145010 @default.
• W2608839610 cites W1989262657 @default.
• W2608839610 cites W1992201016 @default.
• W2608839610 cites W1997158276 @default.
• W2608839610 cites W1997485798 @default.
• W2608839610 cites W2014114774 @default.
• W2608839610 cites W2023744560 @default.
• W2608839610 cites W2041887947 @default.
• W2608839610 cites W2047805127 @default.
• W2608839610 cites W2050695305 @default.
• W2608839610 cites W2050766359 @default.
• W2608839610 cites W2059003657 @default.
• W2608839610 cites W2059141867 @default.
• W2608839610 cites W2064633870 @default.
• W2608839610 cites W2064887945 @default.
• W2608839610 cites W2085146462 @default.
• W2608839610 cites W2094381646 @default.
• W2608839610 cites W2096903378 @default.
• W2608839610 cites W2121745904 @default.
• W2608839610 cites W2122062222 @default.
• W2608839610 cites W2128953914 @default.
• W2608839610 cites W2132036565 @default.
• W2608839610 cites W2135325634 @default.
• W2608839610 cites W2137444863 @default.
• W2608839610 cites W2139499737 @default.
• W2608839610 cites W2150335931 @default.
• W2608839610 cites W2154980334 @default.
• W2608839610 cites W2163954308 @default.
• W2608839610 cites W2170223266 @default.
• W2608839610 cites W2266853406 @default.
• W2608839610 cites W2302672524 @default.
• W2608839610 cites W2315850215 @default.
• W2608839610 cites W2339673691 @default.
• W2608839610 cites W2344163114 @default.
• W2608839610 cites W336748417 @default.
• W2608839610 doi "https://doi.org/10.1016/j.jpeds.2017.03.052" @default.
• W2608839610 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28457525" @default.
• W2608839610 hasPublicationYear "2017" @default.
• W2608839610 type Work @default.
• W2608839610 sameAs 2608839610 @default.
• W2608839610 citedByCount "23" @default.
• W2608839610 countsByYear W26088396102018 @default.
• W2608839610 countsByYear W26088396102019 @default.
• W2608839610 countsByYear W26088396102020 @default.
• W2608839610 countsByYear W26088396102021 @default.
• W2608839610 countsByYear W26088396102022 @default.
• W2608839610 countsByYear W26088396102023 @default.
• W2608839610 crossrefType "journal-article" @default.
• W2608839610 hasAuthorship W2608839610A5035292611 @default.
• W2608839610 hasAuthorship W2608839610A5036816060 @default.
• W2608839610 hasAuthorship W2608839610A5052865753 @default.
• W2608839610 hasAuthorship W2608839610A5060687162 @default.
• W2608839610 hasAuthorship W2608839610A5083808896 @default.
• W2608839610 hasAuthorship W2608839610A5086216178 @default.
• W2608839610 hasConcept C118487528 @default.
• W2608839610 hasConcept C126322002 @default.
• W2608839610 hasConcept C16005928 @default.
• W2608839610 hasConcept C167135981 @default.
• W2608839610 hasConcept C187212893 @default.
• W2608839610 hasConcept C2776194053 @default.
• W2608839610 hasConcept C2776760755 @default.
• W2608839610 hasConcept C2777077863 @default.
• W2608839610 hasConcept C2777138892 @default.
• W2608839610 hasConcept C2777226972 @default.
• W2608839610 hasConcept C2777575956 @default.
• W2608839610 hasConcept C2779134260 @default.
• W2608839610 hasConcept C2780574019 @default.
• W2608839610 hasConcept C2781059491 @default.
• W2608839610 hasConcept C2781301800 @default.
• W2608839610 hasConcept C71924100 @default.
• W2608839610 hasConceptScore W2608839610C118487528 @default.
• W2608839610 hasConceptScore W2608839610C126322002 @default.
• W2608839610 hasConceptScore W2608839610C16005928 @default.
• W2608839610 hasConceptScore W2608839610C167135981 @default.
• W2608839610 hasConceptScore W2608839610C187212893 @default.
• W2608839610 hasConceptScore W2608839610C2776194053 @default.
• W2608839610 hasConceptScore W2608839610C2776760755 @default.
• W2608839610 hasConceptScore W2608839610C2777077863 @default.
• W2608839610 hasConceptScore W2608839610C2777138892 @default.
• W2608839610 hasConceptScore W2608839610C2777226972 @default.
• W2608839610 hasConceptScore W2608839610C2777575956 @default.
• W2608839610 hasConceptScore W2608839610C2779134260 @default.

• next